[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$aard
Aardvark Therapeutics is advancing its Phase X trial for Prader-Willi Syndrome, with recent news of patient enrollment and dosing in Australia. Analysts maintain positive ratings, with some reiterating Buy recommendations and target prices.
About $aard
Aardvark Therapeutics is a biotechnology company focused on developing novel therapeutics for obesity and related disorders.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX +1,034%
1-Year High: XXXXXXX on 2025-07-17
1-Year Low: X on 2025-05-11
Engagements by network (24h): X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +7.30%
X Months: XXXXXX +9,518%
1-Year High: XXXXX on 2025-07-18
1-Year Low: X on 2025-01-27
Mentions by network (24h): X: XX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $aard in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XXXX%
X Month: XXX +33%
X Months: XXXXX +12,066%
1-Year High: XXXXX on 2025-07-18
1-Year Low: X on 2025-01-27
The most influential creators that mention $aard in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXXXX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +8%
X Month: XXX% +11%
X Months: XXX% no change
1-Year High: XXX% on 2025-01-23
1-Year Low: X% on 2025-10-07
Most Supportive Themes:
- Positive Mentions and Engagements: (20%) An increase in positive social media mentions and user engagements indicates growing interest and support for the company's initiatives.
- CEO Stock Purchases: (10%) CEO purchases of company stock signal strong confidence in the company's future prospects and financial health.
Most Critical Themes:
- Analyst Target Price Cut: (15%) A reduction in the target price by an analyst suggests a more cautious outlook on the stock's future performance.
Top $aard Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"BofA $RYTM's PT to $XXX from $XXX reiterated at a Buy rating and said 'Encouraging Early BMI and Hyperphagia Reduction SignalModel Changes' $SLNO $AARD Morgan StanleyPT to $XXX from $XXX reit'd at Buy/said Preliminary Ph2 setmelanotide data in PWS indicate promising and consistent signs of activity (BMI and hyperphagia) despite a challenging population supporting advancement into Ph3. We view early data as encouraging indicating potential to expansion into another blockbuster opportunity. Here's what else BofA had to say:"
X Link @Quantumup1 2025-12-11T18:28Z 3929 followers, 1953 engagements
"Exciting news from $AARD Aardvark Therapeutics advances in Phase X trial for Prader-Willi Syndrome. Patient enrollment surge and global progress set the stage for a Q3 2026 data readout. #PWS #ClinicalTrials 📈🔍"
X Link @notdumbmoney 2025-12-10T23:52Z XXX followers, XX engagements
"$AARD: Aardvark Therapeutics announces first patient dosed in Australia in HERO Phase X trial for prader-willi"
X Link @Briefingcom 2025-12-10T23:07Z 34.5K followers, XXX engagements
"$AARD Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase X Trial for Prader-Willi Syndrome"
X Link @Lycanbull 2025-12-10T21:06Z 8546 followers, XXX engagements